Cambridge Heart Announces REFINE Study Enrollment Completed

Cambridge Heart has announced that the "Risk Estimation Following Infarction -- Noninvasive Evaluation Study (REFINE) has completed its enrollment of 350 patients. The multicenter Canadian study was led by Derek Exner, University of Calgary Associate Professor of Medicine, Libin Cardiovascular Institute of Alberta.

Yahoo News (http://biz.yahoo.com/bw/050207/75907_1.html)